Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

1,274 total articles

Jena Acquisition Corporation II Announces Non-Compliance with Section 802.01B of the NYSE Listed Company Manual which Requires the Company to Maintain a Minimum of 300 Public Stockholders

Jena Acquisition Corporation II Announces Non-Compliance with Section 802.01B of the NYSE Listed Company Manual which Requires the Company to Maintain a Minimum of 300 Public Stockholders

Jena Acquisition Corporation II, a US-listed blank check company on the NYSE, announced it is currently non-compliant with the NYSE's minimum public stockholder requirement of 300 shareholders. The company plans to submit a business plan to return to compliance within 18 months primarily by completing a de-SPAC transaction. During the cure period, …

Wix Announces Final Results of Modified Dutch Auction Tender Offer

Wix Announces Final Results of Modified Dutch Auction Tender Offer

Wix.com Ltd. successfully concluded its modified Dutch auction tender offer, purchasing 17.58 million shares (29.7% of outstanding shares) at $92.00 per share for approximately $1.617 billion. This substantial share buyback highlights the company's confidence in its long-term strategy and commitment to returning value to shareholders amid ongoing d…

ArcelorMittal has published a convening notice for its Annual General Meeting and Extraordinary General Meeting of shareholders to be held on 5 May 2026

ArcelorMittal has published a convening notice for its Annual General Meeting and Extraordinary General Meeting of shareholders to be held on 5 May 2026

ArcelorMittal has issued a convening notice for its Annual General Meeting and Extraordinary General Meeting on May 5, 2026. Key agenda items include the re-election of current board members, the nomination of a new director, Mr. Roy Harvey, former President and CEO of Alcoa, and renewal of board authorization to issue and cancel shares. Relevant d…

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Anika Therapeutics, Inc. announced granting 3,138 restricted stock units (RSUs) to a newly hired non-executive employee as an inducement for employment, under the company's 2021 Inducement Plan and Nasdaq Listing Rule 5635(c)(4). The RSUs will vest over a three-year period contingent on continued service. The grant was approved by the compensation …

IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

IN8bio, a clinical-stage biopharmaceutical company specializing in γδ T cell therapies for cancer and autoimmune diseases, announced an inducement grant of 11,800 stock options to two new employees outside its 2023 Equity Incentive Plan. The options vest over four years and were granted in accordance with Nasdaq listing requirements to incentivize …

Arhaus Expands in Northern Virginia with New Ashburn Showroom

Arhaus Expands in Northern Virginia with New Ashburn Showroom

Arhaus, Inc., a premium home furnishings brand, announced the opening of a 19,300-square-foot showroom in Ashburn, Virginia, marking its fifth location in the state. The showroom offers customers a curated collection of artisan-crafted furniture in a design-forward setting, complemented by complimentary design services and a relaunched Trade Progra…

Spyre Therapeutics Announces Grants of Inducement Awards

Spyre Therapeutics Announces Grants of Inducement Awards

Spyre Therapeutics has granted stock options totaling 70,200 shares to five newly hired non-executive employees as inducement awards. The options have a 10-year term, an exercise price of $48.90 per share, and will vest over four years. This move aims to attract talent and support the company's ongoing clinical development of long-acting antibody t…

Weight Watchers Announces Leadership Transition and Board Updates

Weight Watchers Announces Leadership Transition and Board Updates

WW International, Inc. announced the departure of CEO Tara Comonte and has established an Office of the CEO led by senior executives during the search for a permanent successor. The Board formed a Transition Committee to oversee leadership changes and governance matters. Additionally, Debra Cotter was appointed chief legal officer and secretary. Th…

Denali Therapeutics Regains Full Rights to Investigational Therapy DNL593 (PTV:PGRN) for GRN-related Frontotemporal Dementia (FTD-GRN)

Denali Therapeutics Regains Full Rights to Investigational Therapy DNL593 (PTV:PGRN) for GRN-related Frontotemporal Dementia (FTD-GRN)

Denali Therapeutics announced Takeda's decision to terminate their collaboration on DNL593, a progranulin replacement therapy for frontotemporal dementia linked to GRN mutations. Denali will continue clinical development independently and plans to report Phase 1/2 study results by the end of 2026. The investigational therapy uses Denali's Transport…